BackJasper Therapeutics- Warrants (24/09/2026) Overview
Jasper Therapeutics Inc - Warrants (24/09/2026)

Jasper Therapeutics- Warrants (24/09/2026) Discounted Cash Flow

DCF Analysis for JSPRW.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$1.79

Current Fair Value

$1.79
13262.7% Upside

Undervalued by 13262.7% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading